Regenics vs TMates: Price, doctors, and tirzepatide differences
Regenics vs TMates quickly: Regenics advertises compounded semaglutide starting at $139 first month and compounded tirzepatide at $189 first month, while TMates offers a flat $199/month price that stays the same at every dose. Early verdict: choose Regenics for lower promotional entry pricing and a Sermorelin add-on; choose TMates if you want predictable flat pricing and 24/7 U.S. doctor access.
See Regenics pricing and start options
Key differences at a glance: Regenics vs TMates
This comparison focuses on the most distinctive supported differences: pricing structure, clinical access and oversight, tirzepatide availability and extras, pharmacy compounding and regulatory notes, plus shipping and state coverage.
| Criteria | Regenics | TMates |
|---|---|---|
| Starting price | Semaglutide $139 first month; tirzepatide $189 first month | Flat $199/month at every dose |
| Renewal pricing | Semaglutide renews at $199/month; tirzepatide renews at $279/month | Same price at every dose; no step-up fees |
| Clinical oversight | Licensed nurse practitioners review intake before prescribing | 24/7 access to U.S.-based doctors across all 50 states |
| Tirzepatide availability | Offered as a compounded option | Public detail on tirzepatide limited |
| Additional therapies | Sermorelin peptide add-on offered | No public Sermorelin offering in captured evidence |
| Compounded medication note | Medications are compounded and are not FDA-approved finished products | Compounded medications are not FDA-approved finished products |
| Shipping and coverage | Free shipping; pharmacy network LegitScript certified | Free shipping; licensed coverage in all 50 states |
1. Pricing structure and what to expect
Regenics positions itself as a lower-cost entry point with semaglutide starting at $139 first month and tirzepatide at $189 first month. That promotional pricing applies to the first month only; captured evidence states semaglutide renews at $199/month and tirzepatide at $279/month. TMates offers a flat $199/month model that the provider says remains the same at every dose, with no step-up fees as dosage escalates. If you are budgeting month to month, TMates emphasizes predictability. If you value a cheaper first month and accept higher renewal pricing, Regenics advertises lower initial costs.
View TMates flat pricing and details
2. Clinical access and ongoing oversight
Both platforms are telehealth models, but the captured evidence highlights different clinician structures. Regenics is described as nurse-practitioner-led care with licensed nurse practitioners reviewing intake before prescription. TMates emphasizes 24/7 access to U.S.-based doctors across all 50 states and includes virtual check-ins as part of the program. If continuous physician availability is a priority, TMates documents round-the-clock U.S. doctor access. Regenics focuses on nurse-practitioner oversight and clinician review prior to prescribing.
3. Medication options and extras
Regenics explicitly lists both compounded semaglutide and compounded tirzepatide as available, plus a Sermorelin peptide therapy add-on. TMates focuses on compounded semaglutide with public detail on tirzepatide availability limited in the captured evidence. Patients who want tirzepatide or a peptide add-on will find Regenics presented as offering both in the supplied facts. TMates highlights semaglutide as its primary compounded medication and compares its compound to branded products in mechanism only.
4. Pharmacy, regulation, and safety notes
Both providers use compounded medication models. The source material for each explicitly states that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality. Regenics notes its pharmacy network is LegitScript certified and that medications are compounded by U.S. licensed compounding pharmacies. TMates notes medications are formulated in U.S.-based facilities. Both statements preserve the regulatory qualifier about compounded products.
5. Shipping, state coverage, and payment
Both providers advertise free shipping. TMates highlights licensed coverage in all 50 states and says availability is based on medical eligibility. Regenics notes free shipping and that no insurance is required; it also lists FSA/HSA eligibility. TMates’ captured evidence mentions typical payment options and a direct-pay model in some statements, while Regenics is presented as cash-pay without requiring insurance.
Check Regenics treatments and Sermorelin add-on
Regenics vs TMates: Which to choose
Near-conclusion summary using the primary keyword: Regenics vs TMates splits on price model and clinician availability. Regenics provides lower first-month pricing for semaglutide ($139) and tirzepatide ($189) and offers a Sermorelin add-on, with nurse-practitioner-led review and a LegitScript certified compounding network. TMates charges a flat $199/month that does not increase with dose, and documents 24/7 access to U.S.-based doctors and licensed coverage across all 50 states.
Start Regenics intake and pricing review
Start TMates signup and doctor access
Choose Regenics if…
You want a lower promotional first month for compounded semaglutide or tirzepatide, value a Sermorelin peptide option, and prefer nurse-practitioner-led telehealth with medications compounded in U.S. pharmacies and shipped free.
Choose TMates if…
You prefer predictable flat pricing that stays the same at every dose, want documented 24/7 access to U.S.-based doctors across all 50 states, and value ongoing virtual check-ins with clinically dosed compounded semaglutide.
Regulatory reminder: both providers offer compounded medications, which are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness, or quality.